FLEX PHARMA INC - COM (FLKS)

CUSIP: 33938A105

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
4,961,678
Share change
+194,867
Total reported value
$17,313,024
Price per share
$3.49
Number of holders
27
Value change
+$702,264
Number of buys
13
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 33938A105?
CUSIP 33938A105 identifies FLKS - FLEX PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEX PHARMA INC - COM (FLKS) as of Q4 2017

As of 31 Dec 2017, FLEX PHARMA INC - COM (FLKS) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,961,678 shares. The largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, AMERIPRISE FINANCIAL INC, FRANKLIN RESOURCES INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, ROYCE & ASSOCIATES LP, Vanguard Group Inc, C WorldWide Group Holding A/S, Telemetry Investments, L.L.C., RENAISSANCE TECHNOLOGIES LLC, and Granite Point Capital Management, L.P.. This page lists 27 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.